T Cell Ligand Discovery and Protein Directed Evolution via Lentiviral Surface Display
Exclusively Licensed
Invention type: Technology
/
Case number: #20902
Compositions of retroviruses and methods of using the same for gene delivery are disclosed, wherein the retroviruses comprise a viral envelope protein comprising at least one mutation that diminishes its native function, a non-viral membrane-bound protein comprising a membrane-bound domain and an extracellular targeting domain.
Researchers
Michael Birnbaum
/
Connor Dobson
Departments: Department of Biological Engineering
Technology Areas: Biotechnology: Synthetic Biology / Drug Delivery: Vectors & Virus like Particles
Impact Areas: Healthy Living
-
ligand discovery and gene delivery via retroviral surface display
United States of America | Granted | 12,222,347 -
ligand discovery and gene delivery via retroviral surface display
United States of America | Granted | 12,061,187 -
ligand discovery and gene delivery via retroviral surface display
New Zealand | Pending -
ligand discovery and gene delivery via retroviral surface display
United States of America | Published application -
ligand discovery and gene delivery via retroviral surface display
Japan | Pending -
ligand discovery and gene delivery via retroviral surface display
Australia | Pending -
ligand discovery and gene delivery via retroviral surface display
Brazil | Pending -
ligand discovery and gene delivery via retroviral surface display
Canada | Published application -
ligand discovery and gene delivery via retroviral surface display
China | Published application -
ligand discovery and gene delivery via retroviral surface display
Eurasian Patent Organization | Published application -
ligand discovery and gene delivery via retroviral surface display
European Patent Convention | Published application -
ligand discovery and gene delivery via retroviral surface display
Japan | Granted | 7,658,584 -
ligand discovery and gene delivery via retroviral surface display
India | Published application -
ligand discovery and gene delivery via retroviral surface display
Israel | Pending -
ligand discovery and gene delivery via retroviral surface display
Korea (south) | Published application -
ligand discovery and gene delivery via retroviral surface display
Mexico | Published application -
ligand discovery and gene delivery via retroviral surface display
New Zealand | Pending -
ligand discovery and gene delivery via retroviral surface display
Singapore | Pending -
ligand discovery and gene delivery via retroviral surface display
Hong Kong | Published application -
ligand discovery and gene delivery via retroviral surface display
United States of America | Granted | 12,061,188
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.